140 related articles for article (PubMed ID: 18558334)
1. Production of recombinant tumor necrosis factor receptor/Fc fusion protein by genetically manipulated chickens.
Kyogoku K; Yoshida K; Watanabe H; Yamashita T; Kawabe Y; Motono M; Nishijima K; Kamihira M; Iijima S
J Biosci Bioeng; 2008 May; 105(5):454-9. PubMed ID: 18558334
[TBL] [Abstract][Full Text] [Related]
2. Production of scFv-Fc fusion protein using genetically manipulated quails.
Kawabe Y; Kamihira M; Ono K; Kyogoku K; Nishijima K; Iijima S
J Biosci Bioeng; 2006 Oct; 102(4):297-303. PubMed ID: 17116575
[TBL] [Abstract][Full Text] [Related]
3. Production of recombinant human erythropoietin/Fc fusion protein by genetically manipulated chickens.
Penno CA; Kawabe Y; Ito A; Kamihira M
Transgenic Res; 2010 Apr; 19(2):187-95. PubMed ID: 19653112
[TBL] [Abstract][Full Text] [Related]
4. Transport of human immunoglobulin G and Fc-fusion proteins to chicken egg yolk.
Kawabe Y; Naka T; Ando-Noumi N; Matsumoto H; Ono K; Nishijima K; Kamihira M; Iijima S
J Biosci Bioeng; 2006 Dec; 102(6):518-23. PubMed ID: 17270716
[TBL] [Abstract][Full Text] [Related]
5. Production of chimeric monoclonal antibodies by genetically manipulated chickens.
Kamihira M; Kawabe Y; Shindo T; Ono K; Esaka K; Yamashita T; Nishijima K; Iijima S
J Biotechnol; 2009 Apr; 141(1-2):18-25. PubMed ID: 19428726
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector.
Kamihira M; Ono K; Esaka K; Nishijima K; Kigaku R; Komatsu H; Yamashita T; Kyogoku K; Iijima S
J Virol; 2005 Sep; 79(17):10864-74. PubMed ID: 16103139
[TBL] [Abstract][Full Text] [Related]
8. [Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc].
Xu CX; Yao LH; Zu D; Chen AJ; Huang GJ; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):178-81. PubMed ID: 12148279
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
Hui EK; Boado RJ; Pardridge WM
Mol Pharm; 2009; 6(5):1536-43. PubMed ID: 19624167
[TBL] [Abstract][Full Text] [Related]
10. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
Guo Z; Wang S; Jiao Q; Xu M; Xu Z
Biomed Pharmacother; 2009 Aug; 63(7):537-42. PubMed ID: 18848768
[TBL] [Abstract][Full Text] [Related]
11. [Cloning and expression of human TNFR (P55)-IgG Fc fusion protein in eukaryotic cells].
An N; Xu C; Zhang Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):116-7. PubMed ID: 11436637
[TBL] [Abstract][Full Text] [Related]
12. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
Kwiatkowska EP; Kazimierczak U; Mackiewicz A; Kowalczyk DW
Acta Biochim Pol; 2006; 53(2):361-9. PubMed ID: 16733563
[TBL] [Abstract][Full Text] [Related]
13. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS.
Cao P; Zhang S; Fang Z; Huang H; Bai P; Zhang Q; Luo C
Appl Microbiol Biotechnol; 2008 Feb; 78(2):275-82. PubMed ID: 18189138
[TBL] [Abstract][Full Text] [Related]
14. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
[TBL] [Abstract][Full Text] [Related]
15. A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery.
Asai T; Trinh R; Ng PP; Penichet ML; Wims LA; Morrison SL
Biomol Eng; 2005 Feb; 21(6):145-55. PubMed ID: 15748688
[TBL] [Abstract][Full Text] [Related]
16. Fusion protein of CDR mimetic peptide with Fc inhibit TNF-alpha induced cytotoxicity.
Qin W; Feng J; Li Y; Lin Z; Shen B
Mol Immunol; 2006 Feb; 43(6):660-6. PubMed ID: 15878201
[TBL] [Abstract][Full Text] [Related]
17. Production of human erythropoietin by chimeric chickens.
Kodama D; Nishimiya D; Iwata K; Yamaguchi K; Yoshida K; Kawabe Y; Motono M; Watanabe H; Yamashita T; Nishijima K; Kamihira M; Iijima S
Biochem Biophys Res Commun; 2008 Mar; 367(4):834-9. PubMed ID: 18201556
[TBL] [Abstract][Full Text] [Related]
18. TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis.
Kim JM; Lim BK; Ho SH; Yun SH; Shin JO; Park EM; Kim DK; Kim S; Jeon ES
Biochem Biophys Res Commun; 2006 Jun; 344(3):765-71. PubMed ID: 16631119
[TBL] [Abstract][Full Text] [Related]
19. [Study on methods and requirements for quality control of recombinant human tumor necrosis factor receptor Fc fusion protein].
Zhang Y; Gao K; Han CM; Rao CM; Wang JZ
Yao Xue Xue Bao; 2003 Mar; 38(3):165-8. PubMed ID: 12830708
[TBL] [Abstract][Full Text] [Related]
20. Construction of a novel synergistic system for production and recovery of secreted recombinant proteins by the cell surface engineering.
Shibasaki S; Kawabata A; Ishii J; Yagi S; Kadonosono T; Kato M; Fukuda N; Kondo A; Ueda M
Appl Microbiol Biotechnol; 2007 Jun; 75(4):821-8. PubMed ID: 17345082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
